Trial
NCT04080895
Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects
Phase ITERMINATEDREGULATORYConfidence: HIGH
Sponsor
University of Oxford
Collaborators
Mahidol University; Mahidol Oxford Tropical Medicine Research Unit
Condition
Pharmacokinetic
Intervention
Artemether-lumefantrine
Why stopped
The decision was made due to the expired investigational drug and regulatory changes by the Thai FDA, along with increased importation costs. The research team and investigational drug sponsor agreed to seek approval for early project termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-12